Vesicular stomatitis virus-based therapeutic vaccination targeted to the E1, E2, E6, and E7 proteins of cottontail rabbit papillomavirus
about
Combined administration with DNA encoding vesicular stomatitis virus G protein enhances DNA vaccine potencyVesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus.Reversal of papilloma growth in rabbits therapeutically vaccinated against E6 with naked DNA and/or vesicular stomatitis virus vectors.Long-peptide therapeutic vaccination against CRPV-induced papillomas in HLA-A2.1 transgenic rabbitsUsing HLA-A2.1 Transgenic Rabbit Model to Screen and Characterize New HLA-A2.1 Restricted Epitope DNA Vaccines.Papillomavirus-specific CD4+ T cells exhibit reduced STAT-5 signaling and altered cytokine profiles in patients with recurrent respiratory papillomatosisSmall molecule inhibitors of human papillomavirus protein - protein interactions.The immune response to a vesicular stomatitis virus vaccine vector is independent of particulate antigen secretion and protein turnover rate.Viral vectored granulocyte-macrophage colony stimulating factor inhibits vaccine protection in an SIV challenge model: protection correlates with neutralizing antibody.A vesicular stomatitis virus-based therapeutic vaccine generates a functional CD8 T cell response to hepatitis B virus in transgenic mice.Preventive and Therapeutic Vaccines against Human Papillomaviruses Associated Cervical CancersSingle-dose, therapeutic vaccination of mice with vesicular stomatitis virus expressing human papillomavirus type 16 E7 protein.HPV Vaccines: today and in the Future.Therapeutic vaccination of rabbits with a ubiquitin-fused papillomavirus E1, E2, E6 and E7 DNA vaccine.Perspectives for the development of human papillomavirus vaccines and immunotherapy.Immunologic treatments for precancerous lesions and uterine cervical cancer.Advances in human papilloma virus vaccines: a patent review.The current status and future directions of myxoma virus, a master in immune evasion.Therapeutic human papillomavirus vaccines: current clinical trials and future directions
P2860
Q33649019-FB60BD61-566B-4629-8864-5D311CB7C2FCQ33713083-D6FE01B2-23DC-411B-8408-0FF9B24A4642Q33940220-3B92D069-0675-4001-8507-3CA44043540BQ34193431-A301CFAE-2EA8-4DAE-A591-03A7B5CA2D36Q34978068-A4F39C0B-05F9-4C31-B1A1-F8A8C2FB8BFBQ35072682-D10EAE89-6D74-4497-9F92-0A27EC9C32BBQ35107717-D3F5B83C-CCE4-49DF-B4CC-A4093C75329AQ35867988-5DE0D0F9-77FA-41F5-9233-94ACCB88EA70Q36007614-2A788392-9035-4E39-83CE-3658B667376AQ36607090-4E5FD178-F0B9-41A3-9888-01DE4FBB37CBQ36652548-8E42009C-F1A2-4944-B254-BAC5476EFFF6Q36672543-0BCA2BBC-30D8-48CD-B692-A37DA628556CQ36976268-56B39F1D-CF02-47F4-AB2A-FDEBE6B8734DQ37240133-8EA4FBF2-AE92-4E17-BF8C-C2F869F48204Q37658876-8ECD3B10-7D5A-4E39-AF15-9C0CF738A77BQ37703113-E563E278-D9BB-4A62-8EE0-16335F73994FQ37830705-213E10FC-A37D-43D4-A8A6-107B4B032DDAQ37887080-1B026976-3C47-472A-976C-FC8A40976B4BQ56937332-1476B7A2-1AAE-403C-9474-43BF3C16E081
P2860
Vesicular stomatitis virus-based therapeutic vaccination targeted to the E1, E2, E6, and E7 proteins of cottontail rabbit papillomavirus
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Vesicular stomatitis virus-bas ...... ttontail rabbit papillomavirus
@ast
Vesicular stomatitis virus-bas ...... ttontail rabbit papillomavirus
@en
type
label
Vesicular stomatitis virus-bas ...... ttontail rabbit papillomavirus
@ast
Vesicular stomatitis virus-bas ...... ttontail rabbit papillomavirus
@en
prefLabel
Vesicular stomatitis virus-bas ...... ttontail rabbit papillomavirus
@ast
Vesicular stomatitis virus-bas ...... ttontail rabbit papillomavirus
@en
P2093
P2860
P356
P1433
P1476
Vesicular stomatitis virus-bas ...... ttontail rabbit papillomavirus
@en
P2093
Daniel Zelterman
Janet L Brandsma
John K Rose
Linda Buonocore
Mark Shylankevich
P2860
P304
P356
10.1128/JVI.02835-06
P407
P577
2007-03-28T00:00:00Z